Operation Nasal Vaccine Lightning Speed to Counter COVID-19
Simply ten months after the initial genome sequencing of the SARS-CoV-2 virus, two mRNA vaccines were shown to provide 95% effectiveness against symptomatic infections through randomized, placebo-controlled trials of more than 74,000 individuals.That unprecedented success was partially sustained by the $10 billion governmental investment in Operation Warp Speed (OWS) in March 2020 to accelerate...